Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GRANULES INDIA   MYLAN
EQUITY SHARE DATA
    GRANULES INDIA
Mar-23
MYLAN
Dec-18
GRANULES INDIA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3813,975-   
Low Rs2272,188-   
Sales per share (Unadj.) Rs186.41,829.1-  
Earnings per share (Unadj.) Rs21.349.7-  
Cash flow per share (Unadj.) Rs29.0392.1-  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs116.41,978.8-  
Shares outstanding (eoy) m242.04514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.61.7 96.8%   
Avg P/E ratio x14.262.0 23.0%  
P/CF ratio (eoy) x10.57.9 133.6%  
Price / Book Value ratio x2.61.6 167.8%  
Dividend payout %7.00-   
Avg Mkt Cap Rs m73,6111,585,442 4.6%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m4,2030-   
Avg. sales/employee Rs Th026,887.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.1-  
INCOME DATA
Net Sales Rs m45,119941,074 4.8%  
Other income Rs m1430-   
Total revenues Rs m45,262941,074 4.8%   
Gross profit Rs m9,133243,515 3.8%  
Depreciation Rs m1,845176,206 1.0%   
Interest Rs m55945,262 1.2%   
Profit before tax Rs m6,87222,047 31.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,706-3,507 -48.6%   
Profit after tax Rs m5,16625,554 20.2%  
Gross profit margin %20.225.9 78.2%  
Effective tax rate %24.8-15.9 -156.0%   
Net profit margin %11.42.7 421.7%  
BALANCE SHEET DATA
Current assets Rs m25,741525,495 4.9%   
Current liabilities Rs m18,135383,144 4.7%   
Net working cap to sales %16.915.1 111.5%  
Current ratio x1.41.4 103.5%  
Inventory Days Days1484 17.3%  
Debtors Days Days7793 82.2%  
Net fixed assets Rs m23,290182,553 12.8%   
Share capital Rs m242501 48.3%   
"Free" reserves Rs m27,9270-   
Net worth Rs m28,1691,018,070 2.8%   
Long term debt Rs m1,4861,098,825 0.1%   
Total assets Rs m49,0312,730,861 1.8%  
Interest coverage x13.31.5 893.4%   
Debt to equity ratio x0.11.1 4.9%  
Sales to assets ratio x0.90.3 267.0%   
Return on assets %11.72.6 450.3%  
Return on equity %18.32.5 730.6%  
Return on capital %25.13.2 788.1%  
Exports to sales %81.00-   
Imports to sales %31.30-   
Net fx Rs m22,4060-   
CASH FLOW
From Operations Rs m7,387195,555 3.8%  
From Investments Rs m-1,914-101,081 1.9%  
From Financial Activity Rs m-4,403-91,101 4.8%  
Net Cashflow Rs m1,0681,620 65.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare GRANULES INDIA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare GRANULES INDIA With: VENUS REMEDIES  SHILPA MEDICARE  NECTAR LIFESCIENCE  SUVEN LIFE SCIENCES  ALPA LAB  



Today's Market

Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.